Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-13-052718
Filing Date
2013-07-01
Accepted
2013-07-01 17:28:56
Documents
2
Group Members
FA PRIVATE EQUITY FUND IV GMBH & CO. BETEILIGUNGS KGFA PRIVATE EQUITY FUND IV, L.P.PRODUCTIVITY FUND IV ADVISORS FUND LIQUIDATING TRUSTPRODUCTIVITY FUND IV LIQUIDATING TRUST

Document Format Files

Seq Description Document Type Size
1 SC 13G a13-15998_1sc13g.htm SC 13G 139999
2 EX-99.I a13-15998_1ex99di.htm EX-99.I 5833
  Complete submission text file 0001104659-13-052718.txt   147421
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60689 | Film No.: 13945729
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1 SOUTH WACKER DRIVE SUITE 3900 CHICAGO IL 60606
Business Address
MARSHBANKS TRACY (Filed by) CIK: 0001579618 (see all company filings)

Type: SC 13G